Researchers from the Center for Regenerative Medicine at Boston University and Boston Medical Center announced a new collaboration with the global biopharma company GSK to advance innovative research focused on developing cutting-edge models to study and treat lung diseases like pulmonary fibrosis.
[EurekAlert!]